Back to funds
View filing
Capricorn Fund Managers Ltd
hedge fundUpdated 48 days agoManaged by Capricorn Fund Managers Ltd • Latest filing Q2 2026
Portfolio value
$1.3B
Q2 2026
Filings
13
Quarterly 13F history
Top-10 concentration
98.6%
Weight of largest holdings
Annualized return
65.8%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 13 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q2 2023 | $278.5M |
| Q3 2023 | $288.2M |
| Q4 2023 | $181.8M |
| Q1 2024 | $166.1M |
| Q2 2024 | $141.8M |
| Q3 2024 | $148.5M |
| Q4 2024 | $224.7M |
| Q1 2025 | $187.1M |
| Q2 2025 | $211.6M |
| Q3 2025 | $297.8M |
| Q4 2025 | $414.9M |
| Q1 2026 | $641.4M |
| Q2 2026 | $1.3B |
Top holdings
178 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LPLA LPL Financial Holdings | $54.9M | 194.8K | 4.33% | — |
| 2 | K KKRS KKR & Co | $42.2M | 460.1K | 3.33% | Added(+117.0%) |
| 3 | B BPPFF BP plc | $36.4M | 984.2K | 2.87% | — |
| 4 | R RYDAF Shell plc | $35.6M | 459.2K | 2.81% | — |
| 5 | A APP Applovin Corp | $31.6M | 61.3K | 2.49% | — |
| 6 | C CVNA Carvana Co | $31.3M | 475.0K | 2.46% | Added(+400.0%) |
| 7 | B BRUNW BOOST RUN INC-CL A | $29.1M | 750.0K | 2.29% | — |
| 8 | I INGVF ING Groep NV | $28.2M | 900.0K | 2.23% | — |
| 9 | B BTAFF British American Tobacco plc | $26.9M | 435.3K | 2.12% | Added(+196.1%) |
| 10 | B BAC-PS Bank of America Corp | $26.1M | 457.5K | 2.05% | Trimmed(-14.8%) |
| 11 | B BKD Brookdale Senior Living | $25.3M | 1.57M | 1.99% | — |
| 12 | M MGRB Affiliated Managers Group | $23.4M | 69.0K | 1.84% | — |
| 13 | G GLAXF GSK plc | $22.4M | 426.4K | 1.76% | — |
| 14 | N NRG NRG Energy | $22.1M | 151.0K | 1.74% | — |
| 15 | A AXGN Axogen | $21.5M | 464.9K | 1.69% | Trimmed(-32.4%) |
| 16 | T TSMWF Taiwan Semiconductor Manufacturing Company Ltd | $21.1M | 44.2K | 1.66% | — |
| 17 | R RDDT REDDIT CL A ORD | $20.8M | 120.0K | 1.64% | — |
| 18 | ? N/A Blend Labs | $19.3M | 11.31M | 1.52% | Added(+74.1%) |
| 19 | T TVTX Travere Therapeutics | $18.3M | 321.7K | 1.44% | — |
| 20 | A AVGO Broadcom | $17.9M | 47.5K | 1.41% | — |